Professor Walter E. Morrow Jr., director of Lincoln Laboratory, has been awarded the prestigious National Engineering Award from the American Association of Engineering Societies "for his contributions of inestimable value to the engineering profession and the nation."Awards and Honors
The award was presented in Washington, DC, by James E. Sawyer, AEES's chairman of the board of governors.
"As a distinguished engineer, scientist and business leader, you have advanced the development of programs vital to satellite communications and, in particular, your outstanding contributions to the US space communications program has brought the world closer together," Mr. Sawyer said.
Professor Morrow has received national recognition as a member of the National Academy of Engineering and professional society recognition through the Edwin Howard Armstrong Achievement of the IEEE Communications Society, and by being appointed a fellow of the IEEE.
The citation accompanying the award noted that Professor Morrow has had a long-standing affiliation with MIT since receiving his SB (1949) and SM (1951), and culminating in his continuing appointment, since 1977, as director of Lincoln Laboratory and as a professor of electrical engineering.
Political science graduate student Andrew E. Tauber is one of 40 winners of a Charlotte W. Newcombe Doctoral Dissertation Fellowship for 1995. The Fellows were chosen by the Woodrow Wilson National Fellowship Foundation from 535 applicants, all in their final year of writing dissertations on topics of ethical or religious values. Mr. Tauber's dissertation is entitled "Tyranny on Trial: The Politics of Natural Law and Legal Positivism in the Federal Republic of Germany."
Dr. Kevin J. Yarema, a former graduate student of Professor John Essigman, professor of toxicology and chemistry, has received a Dissertation/Thesis Summary Award from the Drug Information Association. The award consists of a $10,000 cash prize to Dr. Yarema and a duplicate $10,000 unrestricted gift to Dr. Essigman's lab. Dr. Yarema's graduate work suggested ways that the widely used anticancer drug cisplatin could be chemically altered to reduce its mutagenic and therefore potentially carcinogenic properties while retaining its chemotherapeutic effectiveness.
A version of this article appeared in MIT Tech Talk on July 19, 1995.